CCM>Market Reports>
| No. | 05A024 | Survey of Aspirin in China |
About This Report:
| Language version: | English | |
| Document type: | ||
| For ready report -- | ||
| Finished in: | Mar. 2006 (the second edition) | |
| Total pages: | 114 | |
| Delivery: | Immediately by email | |
| Price/copy: | - USD5,000.00 for single user PDF | |
| - USD12,500.00 for corporate license/site license* | ||
| For update report -- | ||
| Will be finished : | within 10-30 working days upon confirmation | |
| Price/copy: | - USD6,500.00 for single user PDF | |
| - USD16,250.00 for corporate license | ||
* The corporate license/site license is only for the sole and confidential use within the subscriber company and its affiliates in which the subscriber company owns, directly or indirectly, a fifty percent or greater, financial interest.
Description:
The report aims to uncover the situation from aspects of production, import & export, consumption, manufacturers and technology. The report focuses on the bulk aspirin, but the major preparations are also introduced. In addition, the overview of analgesic-antipyretic industry and the position of aspirin in it are described in the beginning of this report. Future situation is forecasted. All the active manufacturers of aspirin are profiled.
Main Content:
| Code | Content | Page |
| Executive Summary | 3 |
|
| Introduction and Methodology | 4 |
|
| I | Production and Market | 6 |
| I-1 | Brief Introduction to Analgesic-antipyretic in China | 6 |
| I-1.1 | Brief Introduction to Bulk Analgesic-antipyretic in China | 6 |
| I-1.2 | Position of Aspirin among Analgesic-antipyretic in China | 8 |
| I-1.3 | Paracetamol | 9 |
| I-1.4 | Analgin Sodium | 10 |
| I-1.5 | Aspirin | 11 |
| I-1.6 | Ibuprofen | 11 |
| I-1.7 | Naproxen | 12 |
| I-1.8 | Diclofenac | 14 |
| I-2 | Brief Introduction to the Development History of Aspirin in China | 15 |
| I-3 | Production Situation in the Past Few Years | 17 |
| I-4 | Pricing of Aspirin in the Past Years | 31 |
| I-5 | Import & Export Analysis of Aspirin in the Recent Three Years | 32 |
| I-5.1 | Methodology for the Import & Export Analysis | 32 |
| I-5.2 | Summary of Aspirin Import & Export in the Past Years | 32 |
| I-5.3 | Analysis of Aspirin Export in 2003-2004 | 34 |
| I-5.4 | Analysis of Aspirin Import in 2003-2004 | 38 |
| I-5.5 | Analysis of Aspirin Export in 2005 | 38 |
| I-5.6 | Analysis of Aspirin import in 2005 | 41 |
| I-6 | Character & Problems of Aspirin Industry in China | 42 |
| I-7 | Consumption Pattern of Aspirin in China | 44 |
| I-7.1 | General Application for Aspirin | 44 |
| I-7.2 | Application in Agriculture | 44 |
| I-7.3 | Characters of Aspirin Consumption in China | 45 |
| I-7.4 | Future Growing Points | 46 |
| I-8 | Preparations and Their Usage in Chinese Hospitals | 48 |
| I-8.1 | Physiological Properties of Aspirin | 48 |
| I-8.2 | Major Species of Aspirin Preparations in China | 48 |
| I-9 | Other Issues | 53 |
| I-10 | Key Factors and Driven Forces for the Development in China | 55 |
| II | Technology | 56 |
| III | Future Forecast on Aspirin in the Next 5-10 Years | 64 |
| Conclusion & Suggestion | 66 |
|
| IV | Appendix | 68 |
| IV-1 | Appendix I: Profile of Major Aspirin Manufacturers in China | 68 |
| IV-1.1 | Active Producers | 68 |
| IV-1.1.01 | Shandong Xinhua Pharmaceutical Co., Ltd. | 68 |
| … | …… | … |
| IV-1.1.06 | Hunan Zhongnan Pharmaceutical Co., Ltd. | 88 |
| IV-1.2 | Idle Producers | 92 |
| IV-1.3 | Stopped Producers | 98 |
| IV-2 | Appendix II: Profile of Major Salicylic Acid Manufacturers in China | 104 |
| IV-2.1 | Active Salicylic Acid Producers in China | 104 |
| IV-2.1.01 | Jiangsu Zhenjiang Gaopeng Medicine Co., Ltd. | 104 |
| … | …… | … |
| IV-2.1.06 | Henan Changge Jihong Catalyst Factory | 110 |
| IV-2.2 | Stopped Salicylic Acid Producers in China | 112 |
LIST OF TABLES
Table I-1.1-1 Output of bulk analgesic-antipyretic in China
Table I-1.2-1 Output of analgesic-antipyretic preparation in China between
Table I-1.2-2 Purchasing of some major analgesic-antipyretics in the hospitals in 10 major cities in China, from 1996 to 2003
Table I-1.2-3 Consumption of aspirin in major hospitals in 10 major cities in China during 1997 and 1998
Table I-1.4-1 Output of major analgin manufacturers in China
Table I-1.4-1 Output of Ibuprofen by major manufacturers in China
Table 1-3.1.1-1 Grades of Salicylic Acid in China
Table 1-3.1.1-2 Main Uses of Salicylic Acid
Table 1-3.1.1-3 Production of salicylic acid in the past years
Table 1-3.1.2-1 Production Situation of Acetic Anhydride
Table 1-3.1.2-2 Situation of Acetic Anhydride manufacturers
Table 1-3.2-1 Production of aspirin in the past years
Table 1-3.2-2 Summary of manufacturers of aspirin in China -1
Table 1-3.2-3 Summary of manufacturers of aspirin in China-2
Table 1-3.2-4 Summary of aspirin manufacturers and production in the past years
Table 1-3.2-5 Situation of Aspirin Manufacturers in March 2006
Table I-4-1 Aspirin Price, 1997-2006
Table I-5.1-1 Main items of export data from China Customs
Table I-5.2-1 Import & export of aspirin in the past years
Table I-5.3-1 Top 7 exporters of aspirin in 2003 and 2004
Table I-5.3-2 Export destination of aspirin in 2003 and 2004, top 15
Table I-5.3-3 Export price of aspirin in 2003 and 2004
Table I-5.3-4 Export situation of Chinese manufacturers
Table I-5.4-1 Import situation of aspirin in 2003 and 2004
Table I-5.5-1 Export Price of Aspirin in 2005
Table I-5.5-2 Destination of Aspirin in 2005
Table I-5.5-3 Active Exporter of Aspirin in 2005
Table I-5.5-4 Export Situation of Aspirin Manufacturers in 2005
Table I-5.6-1 Import Situation of Aspirin in 2005
Table I-7.3-1 Aspirin Apparent Consumption in the Past Years
Table I-7.3-2 Aspirin Consumption Pattern in 2005
Table I-8.2-1 Output of different aspirin preparations
Table I-8.2-2 Production and major producers of aspirin tablet in the past years (1)
Table I-8.2-2 Production and major producers of aspirin tablet in the past years (2)
Table I-8.2-3 Guiding rules (temporary) for the price of some medicines such as aspirin issued by the State Planning Committee (effective since Dec. 20, 2002)
Table I-9-1 Duty Imposed on China Aspirin Manufacturers
Table IV-1.1.01-1 Value of “Xinhua” brand
Table IV-1.1.01-2 Manufacturing cost structure of aspirin production in Shandong Xinhua in the past years
Table IV-1.1.01-3 Aspirin grades in Shandong Xinhua
Table IV-1.1.01-4 Production and sales situation of aspirin in Shandong Xinhua in the recent years.
Table IV-1.1.01-4 Production of salicylic acid in Shandong Xinhua
Table IV-1.1.02-2 Situation of aspirin in the past years
Table IV-1.1.04-2 Salicylic acid in Hebei Jingye
Table IV-1.1.04-3 Production of salicylic acid in Jingye Chemical
Table IV-1.1.06-1 Production of aspirin in Hunan Zhongnan in the past years
Table IV-1.2.01-1 Production and sales of Jilin Pharmaceutical in the past years
Table IV-1.2.01-2 Production of salicylic acid in Jilin Henghe
Table IV-1.2.02-1 Production of aspirin in the past years
Part of Report: click here for sample pages
(Note: The following summary is based on the situation in 2006 and maybe different to what it is nowadays. Please be noted.)
- Production
In recent two years, there is no big change in capacity and output. Some manufacturers disclosed the reason is the oversea and domestic market kept steady and the increment rate is low. In March 2006, the capacity of aspirin is xxxx MTs/year, while in 2005 it was xxxx MTs/year. The output in 2005 was xxxx MTs.
Till March 2006, there are xx active manufactures, xx idle manufacturers, and xx stopped manufacturers. XXX is the largest manufacturer, with capacity of xxxx MTs/year.
Ordinary grade aspirin is major product category.
- Import and Export
In 2005, xxxx tons of aspirin were export, while the import volume was xxxx tons.
The major destination are USA (xxxx MTs), Russia (xxxx MTs), and German (xxxx MTs). They accounted for over 60% of total market share in 2005.
Some manufacturers disclosed that the markets in Africa, Southeast Asia, and Central America, increased fast in the latest few years.
- Price
Since 2002, the price of aspirin has kept increasing. In March 2006, the average price reached USD2.90/kg. Increasing price of raw materials is the major reason.
- Consumption
In the last three years, the consumption of aspirin was xxxx MTs annually.
Analgesic-antipyretic and anti blood platelet drug is the major consumer for aspirin. It accounted for xxx% of total consumption.
- Future Forecast
In next 5-10 years, the increment rate of output is xx%, while the capacity will keep xxxx MTs/year in next 2-3 years. No manufactories show aggressive intention in enlarging capacity.
Taking account of the increasing oil price, the price of aspirin will keep rising in next few years.
The consumption volume will increase to xxxx MTs/year in next 10 years. Health care drug, application in agriculture will be the fast growing points.
......
(The rest content of this report is omitted.)
Character of CCM' Report:
|
|||||||||||||||
Remark:
If you are not satisfied with the above main content, or if you would like to add additional requirements to the mentioned subject, or if you could not find your interested item(s) via the search engine, you are advised to go to Single-Client Services and Advisor, or Contact Us.